Company Name or Ticker Symbol
Search for other Categories

Icagen, Inc.  (ICGND)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories

ICGND's Revenue Year on Year Growth by Quarter and Year

Icagen,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
ICGND Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December - 1.00 0.13 0.00
III Quarter September 4.31 0.47 0.07 0.00
II Quarter June 1.16 0.10 0.08 0.00
I Quarter March 0.90 0.03 0.25 0.00
FY   6.37 1.60 0.53 -

Financial Statements
Icagen,'s third quarter 2016 Revenue $ 4.31 millions ICGND's Income Statement
Icagen,'s third quarter 2015 Revenue $ 0.47 millions Quarterly ICGND's Income Statement
ICGND's Growth by Division See ICGND's Growth by Segment

ICGND Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December - 669.23 % - -
III Quarter September 816.62 % 571.43 % - -
II Quarter June 1060 % 25 % - -
I Quarter March 2900 % -88 % - -
FY   - 201.89 % - -

ICGND Revenue Growth Comment
Icagen, Inc. reported Revenue surge of 816.62% year on year in the third quarter, to $ 4.31 millions, this is lower than Icagen, Inc.'s recent average Revenue surge of 843.89%.

According to the results reported in the third quarter, Icagen, Inc. achieved the best Revenue growth in Medical Laboratories industry. While Icagen, Inc.' s Revenue doubling of 816.62% ranks overall at the positon no. 69 in the third quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #19
S&P 500 #69
Revenue Y/Y Growth Statistics
High Average Low
2838.92 % 843.89 % -87.94 %
(Mar 31 2016)   (Mar 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICGND's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ICGND's Competitors
Revenue Growth for Icagen,'s Suppliers
Revenue Growth for ICGND's Customers

You may also want to know
ICGND's Annual Growth Rates ICGND's Profitability Ratios ICGND's Asset Turnover Ratio ICGND's Dividend Growth
ICGND's Roe ICGND's Valuation Ratios ICGND's Financial Strength Ratios ICGND's Dividend Payout Ratio
ICGND's Roa ICGND's Inventory Turnover Ratio ICGND's Growth Rates ICGND's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Sep 30 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2016
Juno Therapeutics, Inc.  1,200.00 %$ 1,200.000 millions
Guided Therapeutics Inc  1,087.50 %$ 1,087.500 millions
Intercept Pharmaceuticals Inc  1,063.37 %$ 1,063.371 millions
Innovus Pharmaceuticals, Inc.  947.12 %$ 947.116 millions
Repros Therapeutics Inc.  900.00 %$ 900.000 millions
Icagen, Inc.  826.05 %$ 826.047 millions
Cytokinetics Inc  643.20 %$ 643.197 millions
Neos Therapeutics, Inc.  616.29 %$ 616.290 millions
China Longyi Group International Holdings Ltd  571.68 %$ 571.678 millions
Eagle Pharmaceuticals, Inc.  559.57 %$ 559.571 millions
Biocept Inc  535.27 %$ 535.270 millions
Acadia Healthcare Company, Inc.  485.99 %$ 485.992 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SFS's Profile
Stock Price
SFS's Financials
SFS's Expectations
Business Description
Charts & Quotes
SFS's News
SFS's Competitors
Customers & Markets
Economic Indicators
SFS's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com